Back-to-School Shortage

Back-to-school shopping for EpiPens is a slog this year. A global shortage of the life-saving devices has parents, drug makers and regulators scrambling for solutions as demand spikes before school starts.

The FDA declared the shortage in May; last week the agency extended the expiration date for certain EpiPen lots by 4 months. The shortage comes as drug-maker Pfizer changes manufacturing processes, after the FDA found several violations including failure to investigate product quality complaints.

EpiPen supply has also been plagued by product recalls, quality issues and spiraling costs. This month, the FDA has approved the first rival generic product intended to drive down prices, set to hit the market in coming months.

The Wall Street Journal

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top